TrialRespiratory research2018

Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.

Barbara Rindlisbacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.